| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |